All research
2026-07-03 PubMed

Interesterified fats rich in palmitic and stearic acids show comparable inflammatory biomarker effects to native palm olein.

Interesterified fats rich in palmitic and stearic acids have comparable effects on selected inflammatory related biomarkers.

Background

The food industry has sought alternatives to partial hydrogenation, which produces trans fatty acids (TFA) known to have significant adverse effects on human health, including increased risk of cardiovascular disease and inflammation. Interesterification is a process used to modify the physical properties of edible oils without generating TFAs. However, there is limited research on the long-term impact of consuming interesterified fats on specific inflammatory biomarkers. Understanding these effects is crucial for developing healthier fat alternatives and ensuring consumer safety, particularly concerning systemic inflammation pathways involving cytokines like IL-6 and TNF-α.

Study Design

Researchers conducted a double-blind, parallel feeding intervention trial involving 90 healthy adults. Participants consumed 50 g of one of three test fats daily for eight weeks, incorporated into two servings of snacks (breakfast and afternoon tea). The three fat groups were: native palm olein (POo), chemically interesterified fat rich in palmitic acid (CIEPO), and chemically interesterified fat rich in stearic acid (CIEBlend). Blood samples were collected at baseline, week zero, week six, and week eight to measure serum levels of interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-α), visfatin, and high-sensitivity C-reactive protein (hsCRP) as primary endpoints.

Results

The study found no significant difference in the serum levels of key inflammatory biomarkers across the three dietary fat groups (POo, CIEPO, and CIEBlend) after eight weeks of intervention. Specifically, interleukin-6 (IL-6) levels remained comparable, indicating no differential impact on this pro-inflammatory cytokine. Similarly, tumour necrosis factor-alpha (TNF-α), another crucial mediator of systemic inflammation, showed no significant changes between groups. Visfatin, an adipokine linked to inflammation and metabolic dysfunction, also exhibited no significant variation. The most widely used clinical marker for inflammation, high-sensitivity C-reactive protein (hsCRP), consistently demonstrated no significant differences among participants consuming the different fat types. This suggests that, for these specific markers, interesterified fats are comparable to native palm olein. > The POo-, CIEPO-, and CIEBlend-diets produced no significant difference in the serum levels of interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-α), visfatin, and high-sensitivity C-reactive protein (hsCRP) over the eight-week study period.

Key Findings

  • No significant difference in IL-6 levels between native palm olein and interesterified fat groups.
  • No significant difference in TNF-α levels between native palm olein and interesterified fat groups.
  • No significant difference in visfatin levels between native palm olein and interesterified fat groups.
  • No significant difference in hsCRP levels between native palm olein and interesterified fat groups.

Why It Matters

This research provides important reassurance regarding the safety of interesterified fats as an alternative to trans fatty acids in food products. Consumers and food manufacturers can consider interesterified fats as a viable option without increased concern for systemic inflammation, at least concerning the biomarkers studied. For those focused on dietary choices and their impact on health, this suggests that the specific type of interesterified fat (palmitic vs. stearic acid rich) may not significantly alter inflammatory profiles in healthy individuals. While this doesn't introduce new protocols for peptide users, it informs the broader context of dietary fat intake, indicating that these fat modifications do not appear to exacerbate inflammatory responses, which is a positive for general health and potentially for individuals managing inflammatory conditions.


interesterified fats palmitic acid stearic acid palm olein inflammation il-6
Source: pubmed:42397442 · Ingested 2026-07-03 · Digest: gemini-2.5-flash